Mbuba, Emmanuel
Odufuwa, Olukayode G.
Moore, Jason
Mmbaga, Selemani
Tchicaya, Emile
Edi, Constant
Chalageri, Vani
Uragayala, Sreehari
Sharma, Amit
Rahi, Manju
Raghavendra, Kamaraju
Eapen, Alex
Koenker, Hannah
Ross, Amanda
Moore, Sarah J.
Funding for this research was provided by:
Moon Netting FZCO, United Arab Emirates
V.K.A. Polymers Pvt Ltd, India
Article History
Received: 1 August 2022
Accepted: 20 January 2023
First Online: 27 January 2023
Declarations
:
: In Tanzania, this study is approved by the Institutional Review Board of Ifakara Health Institute (IHI/IRB/No: 030-2018) and the National Institute for Medical Research (NIMR/HQ/R.8a/Vol. IX/2884). In Côte d’Ivoire, it is approved by the National Committee for Ethics of Life Sciences and Health (036-20/MSHP/CNESVS-km). In India, it is approved by the National Institute of Malaria Research (ECR/NIMR/EC/2018/99), the Institutional Scientific Advisory Committee of NIMR and the Health Minister’s Screening Committee of Indian Council of Medical Research, and the Ministry of Health and Family welfare. If the tunnel test will be required, necessary animal welfare will be adhered following specific country’ guidelines for the use of rabbits in this study. The informed consent form (ICF) is administered to all heads of households or older residents (aged 18 years old and above). The ICF is written in country-specific languages which are either Kiswahili, French or Telegu for Tanzania, Côte d’Ivoire and India, respectively. The ICF explains study objectives and participants’ rights including information that their participation in the study is voluntary and they are free to leave the study at any time they wish. If the household head is unable to read, field workers read out the informed consent form and explain it in clear language to the household heads who cannot read it. A witness from the village is invited to witness during the ICF administration while the respondent signs with their thumb. Also, a written ICF in Kiswahili will be obtained from all participants in the IACT after explaining the purpose, risks, benefits of the experiment, and their rights to free diagnosis and treatment are discussed, and free withdrawal from the experiment any time.
: The permission to publish this manuscript was granted by the National Institute for Medical Research in Tanzania with permission number: Ref. No: NIMR/HQ/P.12 VOL XXXIII/81.
: SJM, EM, OGO, JM, SM, ET, and EC carry out evaluations of vector control products for a number of manufacturers of vector control interventions including ITNs. VC, SU, AS, AE, KR, MR, HK and AR have no conflict of interest. The Veeralin® and MAGNet® ITNs are manufactured by the V.K.A. Polymers Pvt Ltd, India and Tsara® Boost is manufactured by the Moon Netting FZCO from the United Arab Emirates.